类风湿关节炎与颞下颌关节紊乱病的相关性研究进展

doi:10.13591/j.cnki.kqyx.2023.09.017

摘要/Abstract

摘要：

颞下颌关节紊乱病(temporomandibular joint disorder,TMD)是一种常见口腔疾病,病因众多,自身免疫因素中的类风湿关节炎可能是其重要致病因素之一。类风湿关节炎(rheumatoid arthritis,RA)是一种主要累犯小关节的炎症性疾病,由全身性免疫介导且病因不明。颞下颌关节紊乱病与类风湿关节炎常伴行发生,但两者相关的发病机制及相互作用关系仍待进一步的深入研究。该文阐述了颞下颌关节紊乱病与类风湿关节炎之间的相关性,结合流行病学调查结果进行了病因分析,并进一步总结了其治疗与预后的现状,以期为临床医生提供新的诊疗思路。

关键词: 颞下颌关节紊乱病, 类风湿关节炎, 自身免疫

Abstract:

Temporomandibular joint disorder(TMD)is a common oral disease, and its etiology is complex. Rheumatoid arthritis(RA), one of the autoimmune factors, may be an important pathogenic factor. Rheumatoid arthritis is an inflammatory disease that mainly affects joints. It is mediated by systemic immunity and its pathogenesis is unknown. Temporomandibular disorders and rheumatoid arthritis are often accompanied, but the pathogenesis and interaction between them need to be further studied. In this paper, we expound the correlation between temporomandibular disorder and rheumatoid arthritis, analyze the etiology combined with the results of epidemiological investigation, and further summarize the current situation of its treatment and prognosis. We hope to provide a new way of diagnosis and treatment for clinicians.

Key words: temporomandibular joint disorder, rheumatoid arthritis, autoimmunity

中图分类号:

R782.6

滕颖萱, 冯剑颖. 类风湿关节炎与颞下颌关节紊乱病的相关性研究进展[J]. 口腔医学, 2023, 43(9): 861-864.

TENG Yingxuan, FENG Jianying. Research progress of the relationship between rheumatoid arthritis and temporomandibular joint disorders[J]. Stomatology, 2023, 43(9): 861-864.

参考文献 33

[1]	王美青. 𬌗学[M]. 4版. 北京: 人民卫生出版社, 2020.
[2]	Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis[J]. Lancet, 2010, 376(9746):1094-1108. doi: 10.1016/S0140-6736(10)60826-4 pmid: 20870100
[3]	Möller B, Kollert F, Sculean A, et al. Infectious triggers in periodontitis and the gut in rheumatoid arthritis (RA):A complex story about association and causality[J]. Front Immunol, 2020, 11: 1108. doi: 10.3389/fimmu.2020.01108
[4]	González-Chávez SA, Pacheco-Tena C, de Jesús Caraveo-Frescas T, et al. Oral health and orofacial function in patients with rheumatoid arthritis[J]. Rheumatol Int, 2020, 40(3):445-453. doi: 10.1007/s00296-019-04440-3 pmid: 31531708
[5]	Byun SH, Min CY, Choi HG, et al. Increased risk of temporomandibular joint disorder in patients with rheumatoid arthritis: A longitudinal follow-up study[J]. J Clin Med, 2020, 9(9):3005. doi: 10.3390/jcm9093005
[6]	Lin CY, Chung CH, Chu HY, et al. Prevalence of temporomandibular disorders in rheumatoid arthritis and associated risk factors: A nationwide study in Taiwan[J]. J Oral Facial Pain Headache, 2017, 31(4):e29-e36. doi: 10.11607/ofph.1917
[7]	Koh ET, Yap AU, Koh CK, et al. Temporomandibular disorders in rheumatoid arthritis[J]. J Rheumatol, 1999, 26(9):1918-1922. pmid: 10493669
[8]	Donaldson KW. Rheumatoid diseases and the temporomandibular joint: A review[J]. Cranio, 1995, 13(4):264-269. pmid: 9088168
[9]	赵燕平, 马绪臣. 颞下颌关节紊乱病相关疼痛与年龄、性别及骨关节病影像学改变的关系[J]. 中华口腔医学杂志, 2006, 41(12):757-758.
[10]	Chin Jen Sem JP, van der Leeden M, Visscher CM, et al. Prevalence, course, and associated factors of pain in the temporomandibular joint in early rheumatoid arthritis: Results of a longitudinal cohort study[J]. J Oral Facial Pain Headache, 2017, 31(3):233-239. doi: 10.11607/ofph.1606
[11]	Pradeepkiran JA. Insights of rheumatoid arthritis risk factors and associations[J]. J Transl Autoimmun, 2019, 2: 100012. doi: 10.1016/j.jtauto.2019.100012
[12]	Cutolo M, Sulli A, Capellino S, et al. Sex hormones influence on the immune system: Basic and clinical aspects in autoimmunity[J]. Lupus, 2004, 13(9):635-638. pmid: 15485092
[13]	Robinson JL, Soria P, Xu MS, et al. Estrogen promotes mandibular condylar fibrocartilage chondrogenesis and inhibits degeneration via estrogen receptor alpha in female mice[J]. Sci Rep, 2018, 8(1):8527. doi: 10.1038/s41598-018-26937-w
[14]	Wu MJ, Cai JY, Yu YK, et al. Therapeutic agents for the treatment of temporomandibular joint disorders: Progress and perspective[J]. Front Pharmacol, 2021, 11: 596099. doi: 10.3389/fphar.2020.596099
[15]	Robinson JL, Johnson PM, Kister K, et al. Estrogen signaling impacts temporomandibular joint and periodontal disease pathology[J]. Odontology, 2020, 108(2):153-165. doi: 10.1007/s10266-019-00439-1 pmid: 31270648
[16]	Sharma S, Ohrbach R, Fillingim RB, et al. Pain sensitivity modifies risk of injury-related temporomandibular disorder[J]. J Dent Res, 2020, 99(5):530-536. doi: 10.1177/0022034520913247 pmid: 32197057
[17]	谷志远, 张震康, 张熙恩, 等. 颞下颌关节紊乱综合征自身免疫反应的初步探讨[J]. 中华口腔医学杂志, 1990, 25(2):114-116.
[18]	王月娇, 张宁. 国际类风湿关节炎病因学研究热点探析[J]. 中华风湿病学杂志, 2017, 21(12):800-806.
[19]	吕英姿, 高薇. 白细胞介素-17通过信号传导与转录激活因子3诱导类风湿关节炎成纤维样滑膜细胞释放炎症及骨侵蚀因子[J]. 中华风湿病学杂志, 2017, 21(5):338-341.
[20]	Robert M, Miossec P. IL-17 in rheumatoid arthritis and precision medicine: From synovitis expression to circulating bioactive levels[J]. Front Med (Lausanne), 2019, 5: 364.
[21]	Mustafa MA, Al-Attas BA, Badr FF, et al. Prevalence and severity of temporomandibular disorders in rheumatoid arthritis patients[J]. Cureus, 2022, 14(1):e21276.
[22]	Alstergren P, Fredriksson L, Kopp S. Temporomandibular joint pressure pain threshold is systemically modulated in rheumatoid arthritis[J]. J Orofac Pain, 2008, 22(3):231-238. pmid: 18780536
[23]	Covic T, Cumming SR, Pallant JF, et al. Depression and anxiety in patients with rheumatoid arthritis: Prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS)[J]. BMC Psychiatry, 2012, 12: 6. doi: 10.1186/1471-244X-12-6 pmid: 22269280
[24]	Machin AR, Babatunde O, Haththotuwa R, et al. The association between anxiety and disease activity and quality of life in rheumatoid arthritis: A systematic review and meta-analysis[J]. Clin Rheumatol, 2020, 39(5):1471-1482. doi: 10.1007/s10067-019-04900-y pmid: 31897960
[25]	骆丹锋, 魏晓曦, 周颖, 等. 心理因素在颞下颌关节紊乱病诊疗中作用的研究进展[J]. 中华口腔医学杂志, 2020, 55(10):794-798.
[26]	Savtekin G, Sehirli AO. Rheumatoid arthritis in temporo-mandibular joint: A review[J]. Niger J Clin Pract, 2018, 21(10):1243-1246. doi: 10.4103/njcp.njcp_117_18 pmid: 30297553
[27]	Weddell J, Hider S. Diagnosis and management of rheumatoid arthritis[J]. Prescriber, 2021, 32(10):15-20.
[28]	Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis[J]. Lancet, 2017, 389(10086):2338-2348. doi: S0140-6736(17)31491-5 pmid: 28612748
[29]	Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: A review[J]. JAMA, 2018, 320(13):1360-1372. doi: 10.1001/jama.2018.13103 pmid: 30285183
[30]	Dimitroulis G. Management of temporomandibular joint disorders: A surgeon's perspective[J]. Aust Dent J, 2018, 63(Suppl 1):S79-S90.
[31]	Kroese JM, Volgenant CMC, Crielaard W, et al. Temporomandibular disorders in patients with early rheumatoid arthritis and at-risk individuals in the Dutch population: A cross-sectional study[J]. RMD Open, 2021, 7(1):e001485. doi: 10.1136/rmdopen-2020-001485
[32]	Shoohanizad E, Garajei A, Enamzadeh A, et al. Nonsurgical management of temporomandibular joint autoimmune disorders[J]. AIMS Public Health, 2019, 6(4):554-567. doi: 10.3934/publichealth.2019.4.554 pmid: 31909075
[33]	Ouanounou A, Goldberg M, Haas DA. Pharmacotherapy in temporomandibular disorders: A review[J]. J Can Dent Assoc, 2017, 83: h7.